3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neuroblastoma
9
Melanoma
4
Ganglioneuroblastoma
4
Triple Negative Breast Neoplasms
3
Lung Neoplasms
3
Carcinoma, Non-Small-Cell Lung
2
Adenoma, Islet Cell
2
Uveal Melanoma
1
Uterine Cervical Neoplasms
1
Transplant-Related Hematologic Malignancy
1
Squamous Cell Carcinoma of Head and Neck
1
Sarcoma, Alveolar Soft Part
1
Recurrence
1
Prostatic Neoplasms
1
Pathologic Complete Response
1
Neoplasms
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma
1
Locally Advanced Pancreatic Adenocarcinoma
1
Leukemia, Plasma Cell
1
Leukemia, Myeloid, Acute
1
Leukemia
1
Hodgkin Disease
1
Gliosarcoma
1
Glioblastoma
1
Endometrial Neoplasms
1
Carcinosarcoma
1
Carcinoma, Transitional Cell
1
Interventions
X-Rays
7
Specimen Handling
7
Phantoms, Imaging
7
Magnetic Resonance Spectroscopy
6
Nuclear Medicine Department, Hospital
5
Biopsy
5
Cisplatin
4
Vincristine
3
Fluorouracil
3
Doxorubicin
3
Carboplatin
3
ulixertinib
2
tipifarnib
2
tazemetostat
2
sodium thiosulfate
2
selpercatinib
2
palbociclib
2
larotrectinib
2
ivosidenib
2
fludarabine
2
erdafitinib
2
ensartinib
2
Vorinostat
2
Temozolomide
2
Sorafenib
2
Oxaliplatin
2
LY3023414
2
Irinotecan
2
Gemcitabine
2
Etoposide
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Hepatoblastoma
×
sargramostim
×
1 year
×
Clear all
No trials found.